Biosimilar Newsletter Archive
-
11.13.25 -- 100% U.S. Drug Tariffs: Implications For Pharma & Outsourcing
11/13/2025
11/13/25 Biosimilar Development Newsletter
-
11.07.25 -- Closing The Gap Between Discovery And Delivery
11/7/2025
11/07/25 Biosimilar Development Newsletter
-
11.06.25 -- A 5-Step Guide To Achieving Your Biosimilar Milestones On Time
11/6/2025
11/06/25 Biosimilar Development Newsletter
-
10.31.25 -- Looking to outsource pDNA or mRNA process development?
10/31/2025
10/31/25 Biosimilar Development Newsletter
-
10.30.25 -- Navigating The Regulatory Space To Biosimilar Approval
10/30/2025
10/30/25 Biosimilar Development Newsletter
-
10.23.25 -- What If We Had Just One Developability Parameter?
10/23/2025
10/23/25 Biosimilar Development Newsletter
-
10.16.25 -- What You Should Know About USP's Bioassay Updates
10/16/2025
10/16/25 Biosimilar Development Newsletter
-
10.02.25 -- How To Grow CHO Cells Without Cysteine, Tyrosine Feeds
10/2/2025
10/02/25 Biosimilar Development Newsletter
-
09.18.25 -- Reimagining the future of aseptic filling
9/18/2025
09/18/25 Biosimilar Development Newsletter
-
09.11.25 -- How AI Is Revolutionizing Quality Management Systems
9/11/2025
09/11/25 Biosimilar Development Newsletter